Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David H Smith

Showing results (91-100 of 165) with videos related to

Pageof 17
Sort By:
Journal of the American Geriatrics Society|March 6, 2015
Predicting mortality in older adults with kidney disease: a pragmatic prediction modelJessica W Weiss, Robert W Platt, Micah L Thorp, et al.
Journal of the American Heart Association|March 26, 2013
Atrial fibrillation and outcomes in heart failure with preserved versus reduced left ventricular ejection fractionDavid D McManus, Grace Hsu, Sue Hee Sung, et al.
BMC Nephrology|November 24, 2012
Clinician's use of automated reports of estimated glomerular filtration rate: a qualitative studyDavid H Smith, Jennifer Schneider, Micah L Thorp, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 29, 2016
Predicting 5-Year Risk of RRT in Stage 3 or 4 CKD: Development and External ValidationEmily B Schroeder, Xiuhai Yang, Micah L Thorp, et al.
The Permanente Journal|February 5, 2016
Predicting the Risk of Clostridium difficile Infection upon Admission: A Score to Identify Patients for Antimicrobial Stewardship EffortsJennifer L Kuntz, David H Smith, Amanda F Petrik, et al.
The American Journal of Medicine|January 3, 2015
The complex relationship of race to outcomes in heart failure with preserved ejection fractionJerry H Gurwitz, David J Magid, David H Smith, et al.
The American Journal of Managed Care|May 14, 2009
Improving laboratory monitoring of medications: an economic analysis alongside a clinical trialDavid H Smith, Adrianne C Feldstein, Nancy A Perrin, et al.
Pharmacoepidemiology and Drug Safety|June 23, 2018
Diagnosis-based cohort augmentation using laboratory results data: The case of chronic kidney diseaseDavid H Smith, Susan Shetterly, James Flory, et al.
The American Journal of Managed Care|June 4, 2013
More comprehensive discussion of CRC screening associated with higher screeningDavid M Mosen, Adrianne C Feldstein, Nancy A Perrin, et al.
Journal of the American Pharmacists Association : Japha|June 19, 2022
"I really had somebody in my corner." Patient experiences with a pharmacist-led opioid tapering programJennifer L Schneider, Alison J Firemark, Dea Papajorgji-Taylor, et al.
Pageof 17

Showing results (91-100 of 165) with videos related to

Sort By:
Pageof 17
Journal of the American Geriatrics Society|March 6, 2015
Predicting mortality in older adults with kidney disease: a pragmatic prediction modelJessica W Weiss, Robert W Platt, Micah L Thorp, et al.
Journal of the American Heart Association|March 26, 2013
Atrial fibrillation and outcomes in heart failure with preserved versus reduced left ventricular ejection fractionDavid D McManus, Grace Hsu, Sue Hee Sung, et al.
BMC Nephrology|November 24, 2012
Clinician's use of automated reports of estimated glomerular filtration rate: a qualitative studyDavid H Smith, Jennifer Schneider, Micah L Thorp, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 29, 2016
Predicting 5-Year Risk of RRT in Stage 3 or 4 CKD: Development and External ValidationEmily B Schroeder, Xiuhai Yang, Micah L Thorp, et al.
The Permanente Journal|February 5, 2016
Predicting the Risk of Clostridium difficile Infection upon Admission: A Score to Identify Patients for Antimicrobial Stewardship EffortsJennifer L Kuntz, David H Smith, Amanda F Petrik, et al.
The American Journal of Medicine|January 3, 2015
The complex relationship of race to outcomes in heart failure with preserved ejection fractionJerry H Gurwitz, David J Magid, David H Smith, et al.
The American Journal of Managed Care|May 14, 2009
Improving laboratory monitoring of medications: an economic analysis alongside a clinical trialDavid H Smith, Adrianne C Feldstein, Nancy A Perrin, et al.
Pharmacoepidemiology and Drug Safety|June 23, 2018
Diagnosis-based cohort augmentation using laboratory results data: The case of chronic kidney diseaseDavid H Smith, Susan Shetterly, James Flory, et al.
The American Journal of Managed Care|June 4, 2013
More comprehensive discussion of CRC screening associated with higher screeningDavid M Mosen, Adrianne C Feldstein, Nancy A Perrin, et al.
Journal of the American Pharmacists Association : Japha|June 19, 2022
"I really had somebody in my corner." Patient experiences with a pharmacist-led opioid tapering programJennifer L Schneider, Alison J Firemark, Dea Papajorgji-Taylor, et al.
Pageof 17